Cabaletta Bio (CABA) Financials

$3.43

$-0.05 (-1.47%)

As on 04-Sep-2026 11:39EDT

Market cap

$529 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	-0.62	1.65	4.81	1.43	3.68	0.73
Gross Profit	0.62	-1.65	-4.81	-1.43	-3.68	-0.73
Operating Expenses	185.52	172.24	125.14	74.66	54.14	46.31
Operating Profit (EBIT)	-185.52	-172.24	-125.14	-74.66	-54.14	-46.31
Other Income	--	--	--	--	1.16	--
Profit before Tax	-181.32	-167.86	-115.86	-67.68	-52.98	-46.29
Provision for Tax	--	--	--	--	-1.16	-0.76
Profit after Tax (Net Income)	-181.32	-167.86	-115.86	-67.68	-51.81	-45.53
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-52.98	-46.29

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	210.59	112.05	152.34	236.20	104.52	117.96
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	6.23	2.88	5.63	1.46	2.96	2.33
Current Liabilities	39.91	50.15	27.09	15.99	9.49	8.38
Total Liabilities	296.64	165.08	185.05	253.65	116.97	126.34

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	25.70	26.21	22.31	9.16	8.13	1.80
Current Assets	231.03	138.87	166.68	244.49	108.83	124.54
Total Assets	487.76	165.08	185.05	253.65	116.97	126.34
Total Debt*	25.71	27.10	15.60	5.02	5.14	--
Net Current Assets	--	88.72	139.59	228.50	99.35	116.16

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-131.08	-88.22	-53.55	-46.38	-34.11
Cash Flow from Investing Activities	--	-50.27	47.29	-22.45	-27.22	6.00
Cash from Financing Activities	--	100.35	11.68	187.63	32.98	48.90
Net Cash Inflow / Outflow	--	--	--	--	-40.62	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.57	-1.64	-2.31	-1.52	-1.76	-1.61
Cash EPS ($)	--	-1.63	-2.27	-1.49	-1.72	-1.58
Adjusted Book Value ($)	--	1.10	3.03	5.32	3.55	4.16
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.28	-1.76	-1.21	-1.58	-1.20
Free Cash Flow per Share ($)	--	-1.29	-1.80	-1.22	-1.66	-1.24

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-109.32	-56.64	-38.58	-45.53	-40.03
ROE (%)	-112.40	-126.98	-59.64	-39.72	-46.58	-40.03
ROA (%)	-48.11	-95.88	-52.82	-36.52	-42.59	-37.78
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-4,451.12	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-33.01	-44.07	-70.10	-25.00	-16.90	-36.89
Net Profit Growth (%)	-25.67	-44.87	-71.21	-30.62	-13.79	-40.14
EPS Growth (%)	42.20	0.29	-0.52	0.13	-0.10	-0.15
Book Value Growth (%)	-51.70	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.33	-0.98	-14.90	-5.26	-2.36
Price / Book Value	2.73	2.00	0.75	4.27	2.61	0.91
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.44	-0.72	0.30	-11.66	-3.23	0.32
Close Price ($)	3.11	2.19	2.27	22.70	9.25	3.79
High Price ($)	4.23	3.67	26.35	23.77	9.95	15.38
Low Price ($)	1.26	0.99	1.76	5.88	0.59	3.05
Market Cap ($ Cr)	528.98	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.24	0.10	0.02	0.05	--
Short term debt to equity ratio	0.09	0.22	0.07	0.02	0.02	--
Current Ratio	5.79	2.77	6.15	15.29	11.47	14.86
Quick Ratio	5.79	--	--	--	--	--
Interest Coverage	-78.11	-82.76	-153.90	--	-45.96	-63.18

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	1,282.48	359.33	897.76	237.75	890.95
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.